TENAX THERAPEUTICS, INC.

TENX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000034956

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 17, 20269:30 PM ETSep 16, 2026Doogan DeclanDirectorPPurchaseCommon Stock+53K$1.92+$101.76K55.27K+2,330.7%SEC
Sep 15, 20269:38 PM ETSep 11 – Sep 15, 2026Giordano Christopher ThomasCEOPPurchaseCommon Stock+10.85K$1.8514+$20.09K22.17K+95.8%SEC
Sep 15, 20269:30 PM ETSep 11, 2026STAAB THOMAS R IIChief Financial OfficerPPurchaseCommon Stock+5.68K$1.935+$10.98K15.68K+56.8%SEC
Sep 8, 20265:16 PM ETSep 3, 2026Schneeberger Daniel and 1 other10% OwnerPPurchaseCommon Stock+900K$1.7824+$1.6M6.52M+16.0%SEC
Sep 2, 20265:52 PM ETAug 31 – Sep 2, 2026Schneeberger Daniel and 1 other10% OwnerPPurchaseCommon Stock+770.33K$1.7937+$1.38M5.62M+15.9%SEC
Aug 24, 20266:12 PM ETAug 20 – Aug 24, 2026Schneeberger Daniel and 1 other10% OwnerPPurchaseCommon Stock+1.03M$1.7684+$1.81M4.85M+26.8%SEC
Dec 10, 2025Dec 8, 2025Rich StuartChief Medical OfficerPPurchaseCommon Stock+2.5K$10.10+$25.25K5K+100.0%SEC
Dec 10, 2025Dec 9, 2025Rich StuartChief Medical OfficerPPurchaseCommon Stock+2.5K$10.22+$25.55K5.27K+90.4%SEC
Dec 5, 2025Dec 2 – Dec 3, 2025Rich StuartChief Medical OfficerPPurchaseCommon Stock+2.5K$9.052+$22.63K2.77K+939.8%SEC
Dec 5, 2025Dec 4, 2025Rich StuartChief Medical OfficerPPurchaseCommon Stock+2.5K$9.20+$23K2.5KNew positionSEC
Nov 20, 2025Nov 18 – Nov 20, 2025Giordano Christopher ThomasCEOPPurchaseCommon Stock+2.61K$7.675+$19.99K2.61KNew positionSEC
Nov 20, 2025AmendedNov 17 – Nov 18, 2025Almenoff June SherieDirectorPPurchaseCommon Stock+1.99K$7.5027+$14.95K1.99KNew positionSEC
Nov 19, 2025Nov 17, 2025MCGAULEY THOMASInterim CFOPPurchaseCommon Stock+2K$7.34+$14.68K2KNew positionSEC
Nov 19, 2025Nov 17, 2025MCGAULEY THOMASInterim CFOPPurchaseCommon Stock+6K$7.25+$43.5K5KNew positionSEC
Aug 8, 2024Aug 8, 2024PROEHL GERALD TDirectorPPurchaseCommon Stock+1.67K––1.67K+166,600.0%SEC
Aug 8, 2024Aug 8, 2024PROEHL GERALD TDirectorPPurchaseCommon Stock · Derivative+48.31K––16.66K–SEC
Aug 8, 2024Aug 8, 2024Davidson Michael H.DirectorPPurchaseCommon Stock+2.5K––2.88K+656.2%SEC
Aug 8, 2024Aug 8, 2024Davidson Michael H.DirectorPPurchaseCommon Stock · Derivative+72.5K––25K–SEC